FORT MYERS, Fla. — Ridgway, Pa., native Brad Prechtl, MBA, will retire as CEO of Florida Cancer Specialists & Research Institute on July 30, but will stay on as a consultant through April of 2021.
FCS Chief Financial Officer Nathan H. Walcker has been named Chief Executive Officer, effective Aug. 1. Walcker will succeed Prechtl.
Prechtl has served as FCS CEO since October 2009, and through his decade-plus tenure was instrumental in the development and creation of an infrastructure that enabled the company to become a nationally recognized community oncology practice leader.
Under his leadership, FCS achieved many significant milestones that included the expansion of clinical sites, physicians and staff to ensure patients battling cancer have access to the highest quality care in their local communities. Prechtl was also instrumental in the development and growth of imaging, specialty pharmacy, care management, pathology services and clinical trials/research.
“I am deeply honored to have had the opportunity to steer such an innovative organization over the last 10-plus years,” said Prechtl. “FCS has developed and grown with the singular goal of consistently providing the highest quality of value-based cancer care. I am very proud of all that we’ve accomplished and have been inspired every day by the dedication and commitment of my colleagues, physicians, clinicians and employees, and the courage and perseverance of our patients,” Prechtl concluded.
Walcker joined FCS in August 2019, bringing more than a decade of healthcare, physician services and corporate finance expertise with him to Fort Myers.
